International Randomized Study of Interferon Vs STI571 (IRIS) 8-Year Follow up: Sustained Survival and Low Risk for Progression or Events in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib

Professor Stephen O'Brien

International Randomized Study of Interferon Vs STI571 (IRIS) 8-Year Follow up: Sustained Survival and Low Risk for Progression or Events in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib Lookup NU author(s) Professor Stephen O'Brien



Author(s)		Deininger M, O'Brien SG, Guilhot F, Goldman JM, Hochhaus A, Hughes TP, Radich JP, Hatfield AK, Mone M, Filian J, Reynolds J, Gathmann I, Larson RA, Druker BJ
Editor(s)
Publication type		Conference Proceedings (inc. Abstract)
Conference Name		Blood: 51st Annual Meeting of the American Society of Hematology
Conference Location		New Orleans, LA
Year of Conference		2009
Date		5-8 December 2009
Volume		114, 22
Pages		462

ISBN




Full text for this publication is not currently held within this repository. Alternative links are provided below where available.



Publisher		American Society of Hematology

Actions
Library holdings		Search Newcastle University Library for this item